- Home
- INTZ vs ENLV Comparison
INTZ vs ENLV Comparison
Compare INTZ & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTZ
- ENLV
- Stock Information
- Founded
- INTZ 1983
- ENLV 2005
- Country
- INTZ United States
- ENLV Israel
- Employees
- INTZ N/A
- ENLV N/A
- Industry
- INTZ Computer Communications Equipment
- ENLV Biotechnology: Pharmaceutical Preparations
- Sector
- INTZ Telecommunications
- ENLV Health Care
- Exchange
- INTZ Nasdaq
- ENLV Nasdaq
- Market Cap
- INTZ 31.8M
- ENLV 25.5M
- IPO Year
- INTZ 2020
- ENLV 1995
- Fundamental
- Price
- INTZ $1.81
- ENLV $1.13
- Analyst Decision
- INTZ Buy
- ENLV Strong Buy
- Analyst Count
- INTZ 2
- ENLV 2
- Target Price
- INTZ $7.00
- ENLV $10.00
- AVG Volume (30 Days)
- INTZ 235.3K
- ENLV 175.2K
- Earning Date
- INTZ 11-07-2025
- ENLV 08-29-2025
- Dividend Yield
- INTZ N/A
- ENLV N/A
- EPS Growth
- INTZ N/A
- ENLV N/A
- EPS
- INTZ N/A
- ENLV N/A
- Revenue
- INTZ $6,828,000.00
- ENLV N/A
- Revenue This Year
- INTZ $36.75
- ENLV N/A
- Revenue Next Year
- INTZ $30.90
- ENLV N/A
- P/E Ratio
- INTZ N/A
- ENLV N/A
- Revenue Growth
- INTZ 25.86
- ENLV N/A
- 52 Week Low
- INTZ $0.35
- ENLV $0.81
- 52 Week High
- INTZ $7.34
- ENLV $2.10
- Technical
- Relative Strength Index (RSI)
- INTZ 51.09
- ENLV 57.20
- Support Level
- INTZ $1.58
- ENLV $1.01
- Resistance Level
- INTZ $1.87
- ENLV $1.08
- Average True Range (ATR)
- INTZ 0.12
- ENLV 0.04
- MACD
- INTZ 0.01
- ENLV 0.02
- Stochastic Oscillator
- INTZ 52.38
- ENLV 87.86
About INTZ Intrusion Inc.
Intrusion Inc is a cybersecurity company based in Plano, Texas. The group offers customers to access its threat intelligence database containing the historical data, known associations, and reputational behavior of Internet Protocol (IP) addresses. The company's product consists of On-Premise Network Protection, Cyber Threat Consulting, Cloud Network Security, and Endpoint Protection. Its solutions are INTRUSION Shield, INTRUSION TraceCop, and INTRUSION Savant. Its end-user customers include the U.S. federal government, state and local government entities, large and diversified conglomerates, and manufacturing entities.
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.